To date, single-nucleotide polymorphisms (SNPs) in STAT3 have shown significant associations with cervical cancer, nonsmall cell lung cancer, leukemia, prostate cancer, and hepatocellular cancer [20–24]. Here, STAT3 is linked to hepatocellular carcinoma.